Igc Bio Financing
Igc Bio Inc., Corporation just filed form D because of $2.50 million equity financing. This is a new filing. Igc Bio was able to sell $2.50 million. That is 100.00% of the offering. The total financing amount was $2.50 million. The offering form was filed on 2016-10-14. The reason for the financing was: No payments have been proposed other than payments of salaries in the ordinary course of business..
Igc Bio is based in Massachusetts. The firm’s business is Biotechnology. The SEC form was filed by Tamar Erdfarb Secretary. The company was incorporated in 2014. The filler’s address is: 50 Congress Street, Suite 1040, Boston, Ma, Massachusetts, 02109. Tamar Erdfarb is the related person in the form and it has address: C/O Igc Bio Inc., 50 Congress Street, Suite 1040, Boston, Ma, Massachusetts, 02109. Link to Igc Bio Filing: 000166805116000002.
Analysis of Igc Bio Offering
On average, firms in the Biotechnology sector, sell 73.77% of the total offering amount. Igc Bio sold 100.00% of the offering. Could this mean that the trust in Igc Bio is high? The average investment offering size for companies in the Biotechnology industry is $3.08 million. The offering was 18.83% smaller than the average of $3.08 million. Of course this should not be taken as negative. Firms raise funds for different reasons and needs. The minimum investment for this offering was set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Igc Bio Also
The Form D signed by Tamar Erdfarb might help Igc Bio Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.